Dorothy Hatsukami, PhD

Professor, Department of Psychiatry

Dorothy Hatsukami

Contact Info

hatsu001@umn.edu

Office Phone 612-626-2121

Fax 612-624-4610

Office Address:
Dorothy Hatsukami, Ph.D.
717 Delaware St SE
Minneapolis, MN 55414

Professor, Department of Psychiatry

Associate Director, Cancer Prevention and Control, Masonic Cancer Center (MCC)


PhD, Clinical Psychology, University of Minnesota

BA, University of California - Berkeley

Internship, Clinical Psychology, University of Washington-Seattle

Summary

Dorothy K. Hatsukami, PhD, is the Forster Family Chair in Cancer Prevention at the Masonic Cancer Center of the University of Minnesota and Professor of Psychiatry. She is the Associate Director of Cancer Prevention and Control at the University of Minnesota Masonic Cancer Center and Director of the Tobacco Research Programs. Her areas of expertise include nicotine addiction and its treatment, including testing medications such as a nicotine vaccine and combination medications, in smokers. She has over 400 publications and is currently PI/Co-PI of two large NIH-funded cooperative agreements that involve assessing the toxicity, appeal and addictiveness of various tobacco products. She has served on numerous scientific advisory boards for the U.S. government including the 1) Food and Drug Administration, Tobacco Product Scientific Advisory Committee, 2) National Advisory Council on Drug Abuse, 3) Interagency Committee on Smoking and Health, 4) Substance Abuse and Mental Heal Services Administration, 5) Scientific Board of Counselors for the National Institutes on Drug Abuse, and 6) the Drug Control Research, Data and Evaluation Committee of the Office on National Drug Control Policy. She is currently a member of the World Health Organization Study Group on Tobacco Product Regulation. is the Forster Family Chair in Cancer Prevention at the Masonic Cancer Center of the University of Minnesota and Professor of Psychiatry. She is the Associate Director of Cancer Prevention and Control at the University of Minnesota Masonic Cancer Center and Director of the Tobacco Research Programs. Her areas of expertise include nicotine addiction and its treatment, including testing medications such as a nicotine vaccine and combination medications, in smokers. She has over 400 publications and is currently PI/Co-PI of two large NIH-funded cooperative agreements that involve assessing the toxicity, appeal and addictiveness of various tobacco products. She has served on numerous scientific advisory boards for the U.S. government including the 1) Food and Drug Administration, Tobacco Product Scientific Advisory Committee, 2) National Advisory Council on Drug Abuse, 3) Interagency Committee on Smoking and Health, 4) Substance Abuse and Mental Heal Services Administration, 5) Scientific Board of Counselors for the National Institutes on Drug Abuse, and 6) the Drug Control Research, Data and Evaluation Committee of the Office on National Drug Control Policy. She is currently a member of the World Health Organization Study Group on Tobacco Product Regulation.

Professional Associations

  • Forster Family Chair in Cancer Prevention
  • Society for Research on Nicotine and Tobacco
  • College on Problems of Drug Dependence
  • American Association for Cancer Research
  • American Psychological Association

Research

Research Summary/Interests

  • Tobacco Addiction
  • Tobacco Regulatory Science
  • Cancer Prevention

Teaching

Teaching Areas

Dr. Hatsukami lectures on tobacco addiction, treatment, and policies.

Clinical

Clinical Interests

Tobacco cessation